![8-[4-(4-Fluorophenyl)-4-Oxobutyl]-3-[2-(4-Isothiocyanatophenyl)Ethyl]-1-Phenyl-1,3,8-Triazaspiro[4…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FFF103065.webp&w=3840&q=75)

8-[4-(4-Fluorophenyl)-4-Oxobutyl]-3-[2-(4-Isothiocyanatophenyl)Ethyl]-1-Phenyl-1,3,8-Triazaspiro[4.5]Decan-4-One
CAS:
Ref. 3D-FF103065
![8-[4-(4-Fluorophenyl)-4-Oxobutyl]-3-[2-(4-Isothiocyanatophenyl)Ethyl]-1-Phenyl-1,3,8-Triazaspiro[4…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FFF103065.webp&w=3840&q=75)

Product Information
Name:8-[4-(4-Fluorophenyl)-4-Oxobutyl]-3-[2-(4-Isothiocyanatophenyl)Ethyl]-1-Phenyl-1,3,8-Triazaspiro[4.5]Decan-4-One
Brand:Biosynth
Description:The objective of this study was to develop a predictive algorithm for the diagnosis of congenital cytomegalovirus (CMV) infection in infants. The algorithm, which is based on maternal blood and infant blood samples, was developed using logistic regression with a validation dataset. The algorithm has been evaluated on a large dataset of infants and found to have good clinical relevance. It can be used as an alternative screening test for CMV infection in infants born to mothers who are at risk for having the virus, such as those carrying HCMV or HIV.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:556.69 g/mol
Formula:C32H33FN4O2S
Purity:Min. 95%